Lag0s:
|
mRNA cancer vaccine
Week Summary
Technology
  • Earth has captured a temporary 'second moon,' a small asteroid named 2024 PT5, which will orbit until November 2024.
  • Research indicates that larger AI chatbots are increasingly prone to generating incorrect answers, raising concerns about their reliability.
  • Meta's Chief Technical Officer discussed advancements in AR and VR technologies, particularly focusing on the Orion AR glasses.
  • The author reflects on their experience with Rust, proposing several changes to improve the language's usability and safety features.
  • The Tor Project and Tails OS have merged to enhance their efforts in promoting online anonymity and privacy.
  • OpenAI is undergoing leadership changes, with key executives departing amid discussions about restructuring and the company's future direction.
  • Git-absorb
  • The concept of critical mass explains how significant changes occur when a threshold of acceptance is reached, impacting technology and society.
  • WordPress.org has banned WP Engine from accessing its resources due to ongoing legal disputes, raising concerns about security for WP Engine customers.
  • PostgreSQL 17
  • Hotwire Native is a web-first framework that simplifies mobile app development, allowing developers to reuse HTML and CSS across platforms.
  • Radian Aerospace is progressing on a reusable space plane, completing ground tests and aiming for full-scale flights by 2028.
  • A groundbreaking diabetes treatment using reprogrammed stem cells has enabled a patient to produce insulin independently for over a year.
  • Apple is developing a new home accessory that combines features of the iPad, Apple TV, and HomePod, expected to launch in 2025.
  • SpaceX's Starlink service is set to surpass 4 million subscribers, reflecting rapid growth and significant revenue projections.
  • TinyJS is a lightweight JavaScript library that simplifies dynamic HTML element creation and DOM manipulation for developers.
  • Moderna's mRNA cancer vaccine shows promising trial results for melanoma and head and neck cancer, boosting survival rates.

    Moderna's mRNA cancer vaccine, developed to target melanoma, might also treat a form of head and neck cancer. Data from an early trial showed a greater survival rate for patients who took Moderna's cancer vaccine alongside immunotherapy treatments. The news sent Moderna's share price soaring.

    Hi Impact
    ModernamRNA cancer vaccineHealthcare
    Thursday, April 11, 2024
  • mRNA cancer vaccine for melanoma shows promising trial results, significantly reducing the risk of recurrence.

    A mRNA cancer vaccine for melanoma halves the risk of patients dying or the disease returning after three years. The vaccine is custom-built for each patient and specific to each patient's tumor. The average risk of recurrence for the type of advanced cancer the study focused on is 50%, but the vaccine brought the risk of recurrence down to 25%. The data from the study suggests that levels of cancer relapse did not increase in people with high-risk, advanced-stage melanoma.

    Hi Impact
    mRNA cancer vaccinemelanoma
Month Summary
Technology
  • OpenAI is considering a new subscription model for its upcoming AI product, Strawberry, while also restructuring for better financial backing.
  • Telegram founder
  • The startup landscape is shifting towards more tech-intensive ventures, with a focus on specialized research and higher capital requirements.
  • Boom Supersonic's XB-1 demonstrator aircraft successfully completed its second flight, testing new systems for future supersonic travel.
  • announced the uncrewed return of Boeing's Starliner, with future crewed missions planned for 2025.
  • OpenAI's SearchGPT aims to compete with Google Search by providing AI-driven information retrieval, though it currently faces accuracy issues.
  • Tesla is preparing to unveil its autonomous robotaxi technology at an event in Los Angeles, indicating ongoing challenges in achieving full autonomy.
  • The US Department of Justice is investigating Nvidia for potential antitrust violations related to its AI chip market dominance.
  • Apple plans to use OLED screens in all iPhone 16 models, moving away from Japanese suppliers and introducing new AI features.
  • Amazon S3 has introduced conditional writes to prevent overwriting existing objects, simplifying data updates for developers.
  • Chinese scientists have developed a hydrogel that shows promise in treating osteoarthritis by restoring cartilage lubrication.
  • Nvidia's CEO is working to position the Nvidia as a comprehensive provider for data center needs, amidst growing competition from AMD and Intel.
  • OpenAI
  • Nvidia Blackwell
  • Amazon is set to release a revamped Alexa voice assistant in October, powered by AI models from Anthropic's Claude, and will be offered as a paid subscription service.